November 10, 2026

Oklahoma Pharmacies to Receive Settlement Funds from CVS Caremark Dispute

Over $2.1 million will be allocated to Oklahoma pharmacies from a settlement with CVS Caremark, as announced by state officials. Attorney General Gentner Drummond and Insurance Commissioner Glen Mulready reported that more than 900 pharmacies will benefit from this payout. This action follows a legal challenge regarding alleged improper transaction fees charged by CVS Caremark in processing prescription claims.

Drummond emphasized the vital role of pharmacies, particularly in rural Oklahoma. He stated, “Pharmacies are essential to the health and well-being of Oklahoma communities.” His office is focused on ensuring that funds reach those pharmacies unfairly charged and plans to maintain accountability for pharmacy benefit managers (PBMs) when they break Oklahoma laws.

The settlement amount comes from penalties collected in an agreement reached between CVS Caremark and the Oklahoma Insurance Department in 2022. Unlike other settlements, this payment will not go to CVS customers. Instead, eligible pharmacies will be contacted directly by the Attorney General’s Office with data provided by the Oklahoma State Board of Pharmacy. The office will also assist these pharmacies with the necessary paperwork to obtain their payments.

Context and Implications

While customers will not receive direct compensation, the dispute highlights the scrutinized role of PBMs in influencing pharmacy payments for prescriptions. CVS Caremark functions as a PBM, supervising pharmacy benefits and transactions for health plans. Oklahoma accused the company of improperly levying transaction fees on pharmacies between September 2020 and October 2021.

Notably, this marks the third settlement involving CVS Caremark. Combined, these settlements have reimbursed over $7 million to Oklahoma pharmacies.

Details of the Settlement

The settlement, finalized in January 2022, arose from claims that CVS Caremark imposed unlawful transaction fees on pharmacies. While the company did not admit to any wrongdoing under the agreement, the controversy draws attention to financial strains that smaller pharmacies face due to hefty transaction costs.

A customer’s copay might seem routine, but for pharmacies, the actual costs involve more complexity. These include drug expenses and deductions by intermediaries, said finance expert Michael Ryan. He warned against assuming small independent pharmacies can absorb these expenses indefinitely.

Alex Beene, a financial literacy instructor, remarked, This settlement is primarily intended for pharmacies in Oklahoma, rather than direct customer compensation. He explained the responsibility of the Attorney General’s Office in managing and distributing the funds to the pharmacies impacted.

This latest development is set in a backdrop of previous agreements, such as a 2025 settlement worth over $5 million concerning allegations of underpayment for drug dispensing.

The Path Forward

The Attorney General’s Office will direct the redistribution of the settlement funds to the appropriate pharmacies. Despite this, there remains concern over the longer-term impact of alleged unfair fees.

Ryan noted that while settlement proceeds can amend some financial stresses, they do not assure continued pharmacy operations under future insurance terms.

TAGS: